Hypertrophy, Left Ventricular
"Hypertrophy, Left Ventricular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Descriptor ID |
D017379
|
| MeSH Number(s) |
C14.280.195.400 C23.300.775.250.400
|
| Concept/Terms |
Hypertrophy, Left Ventricular- Hypertrophy, Left Ventricular
- Left Ventricular Hypertrophy
- Hypertrophies, Left Ventricular
- Left Ventricular Hypertrophies
- Ventricular Hypertrophies, Left
- Ventricular Hypertrophy, Left
|
Below are MeSH descriptors whose meaning is more general than "Hypertrophy, Left Ventricular".
Below are MeSH descriptors whose meaning is more specific than "Hypertrophy, Left Ventricular".
This graph shows the total number of publications written about "Hypertrophy, Left Ventricular" by people in this website by year, and whether "Hypertrophy, Left Ventricular" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 4 | 1 | 5 |
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 3 | 3 |
| 1998 | 2 | 1 | 3 |
| 1999 | 4 | 0 | 4 |
| 2000 | 2 | 1 | 3 |
| 2001 | 3 | 0 | 3 |
| 2002 | 2 | 0 | 2 |
| 2003 | 4 | 1 | 5 |
| 2004 | 2 | 4 | 6 |
| 2005 | 1 | 2 | 3 |
| 2006 | 4 | 2 | 6 |
| 2007 | 3 | 3 | 6 |
| 2008 | 3 | 0 | 3 |
| 2009 | 2 | 0 | 2 |
| 2010 | 3 | 2 | 5 |
| 2011 | 5 | 0 | 5 |
| 2012 | 2 | 2 | 4 |
| 2013 | 1 | 1 | 2 |
| 2014 | 4 | 1 | 5 |
| 2015 | 3 | 0 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 1 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 2 | 2 | 4 |
| 2020 | 4 | 1 | 5 |
| 2021 | 1 | 1 | 2 |
| 2022 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypertrophy, Left Ventricular" by people in Profiles.
-
Thirty years with LIFE-a randomized clinical trial with more than 200 published articles on clinical aspects of left ventricular hypertrophy. Blood Press. 2022 12; 31(1):125-128.
-
Ensemble machine learning model identifies patients with HFpEF from matrix-related plasma biomarkers. Am J Physiol Heart Circ Physiol. 2022 05 01; 322(5):H798-H805.
-
Prevalence and Cumulative Risk of Familial Idiopathic Dilated Cardiomyopathy. JAMA. 2022 02 01; 327(5):454-463.
-
Ubiquitin ligase Wwp1 gene deletion attenuates diastolic dysfunction in pressure-overload hypertrophy. Am J Physiol Heart Circ Physiol. 2021 11 01; 321(5):H976-H984.
-
Comparison of Dialysis Unit and Home Blood Pressures: An Observational Cohort Study. Am J Kidney Dis. 2021 11; 78(5):640-648.
-
The ubiquitin ligase WWP1 contributes to shifts in matrix proteolytic profiles and a myocardial aging phenotype with diastolic heart. Am J Physiol Heart Circ Physiol. 2020 10 01; 319(4):H765-H774.
-
Pressure overload generates a cardiac-specific profile of inflammatory mediators. Am J Physiol Heart Circ Physiol. 2020 08 01; 319(2):H331-H340.
-
Longitudinal Changes in Cardiac Structure and Function in Severe Obesity: 11-Year Follow-Up in the Utah Obesity Study. J Am Heart Assoc. 2020 06 16; 9(12):e014542.
-
The Calcineurin-TFEB-p62 Pathway Mediates the Activation of Cardiac Macroautophagy by Proteasomal Malfunction. Circ Res. 2020 07 31; 127(4):502-518.
-
Lean body mass is the strongest anthropometric predictor of left ventricular mass in the obese paediatric population. Cardiol Young. 2020 Apr; 30(4):476-481.